- Home
- QIPT vs TELA Comparison
QIPT vs TELA Comparison
Compare QIPT & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QIPT
- TELA
- Stock Information
- Founded
- QIPT 1993
- TELA 2012
- Country
- QIPT United States
- TELA United States
- Employees
- QIPT N/A
- TELA N/A
- Industry
- QIPT
- TELA Medical/Dental Instruments
- Sector
- QIPT
- TELA Health Care
- Exchange
- QIPT Nasdaq
- TELA Nasdaq
- Market Cap
- QIPT 129.3M
- TELA 112.5M
- IPO Year
- QIPT N/A
- TELA 2019
- Fundamental
- Price
- QIPT $2.96
- TELA $2.63
- Analyst Decision
- QIPT Strong Buy
- TELA Strong Buy
- Analyst Count
- QIPT 3
- TELA 4
- Target Price
- QIPT $7.67
- TELA $9.25
- AVG Volume (30 Days)
- QIPT 279.7K
- TELA 166.5K
- Earning Date
- QIPT 02-12-2025
- TELA 11-07-2024
- Dividend Yield
- QIPT N/A
- TELA N/A
- EPS Growth
- QIPT N/A
- TELA N/A
- EPS
- QIPT N/A
- TELA N/A
- Revenue
- QIPT $245,915,000.00
- TELA $68,649,000.00
- Revenue This Year
- QIPT $7.34
- TELA $30.39
- Revenue Next Year
- QIPT $6.20
- TELA $25.51
- P/E Ratio
- QIPT N/A
- TELA N/A
- Revenue Growth
- QIPT 16.17
- TELA 29.34
- 52 Week Low
- QIPT $2.30
- TELA $2.30
- 52 Week High
- QIPT $4.99
- TELA $7.84
- Technical
- Relative Strength Index (RSI)
- QIPT 54.31
- TELA 37.77
- Support Level
- QIPT $2.80
- TELA $2.57
- Resistance Level
- QIPT $3.13
- TELA $2.88
- Average True Range (ATR)
- QIPT 0.18
- TELA 0.19
- MACD
- QIPT 0.00
- TELA -0.03
- Stochastic Oscillator
- QIPT 64.46
- TELA 11.34
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.